Bisocor Plus 2.5/6.25 Tablet

Overview

Bisocor Plus 2.5/6.25 Tablet contains a fixed-dose combination of Bisoprolol Fumarate and Hydrochlorothiazide, manufactured by Square Pharmaceuticals PLC. It is used in the management of hypertension, particularly when blood pressure is not adequately controlled on either agent alone.

Dosage and Administration

Usually 1 tablet once daily in the morning, or as advised by the physician, based on individual blood pressure response.

Interaction

Concomitant use with other antihypertensives, NSAIDs, lithium, or other diuretics may alter blood pressure control and electrolyte balance. Caution with calcium channel blockers and antidiabetic agents.

Contraindications

Contraindicated in severe renal impairment, anuria, refractory hypotension, acute heart failure, severe bradycardia, AV block, and known hypersensitivity to sulfonamide-derived drugs.

Side Effects

Dizziness, fatigue, hypotension, electrolyte disturbances (hypokalemia), and gastrointestinal upset.

Pregnancy and Lactation

Not recommended during pregnancy and lactation unless clearly necessary and under close medical supervision, due to risks associated with both components.

Precautions and Warnings

Should not be discontinued abruptly. Monitor electrolytes and renal function periodically, particularly in elderly patients or those with renal impairment.

Storage Conditions

Store below 30°C, in a dry place, protected from light and moisture. Keep out of the reach of children.

Frequently Asked Questions

What is Bisocor Plus used for?
It is used to treat high blood pressure when a single antihypertensive agent does not provide adequate control.

Does it affect electrolyte levels?
Yes, the hydrochlorothiazide component can lower potassium levels; periodic monitoring may be advised by your physician.

This content is for informational purposes only and does not substitute professional medical advice. Please consult a registered physician before taking any medication.